Adar1 Capital Management, LLC Anavex Life Sciences Corp. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 16,221 shares of AVXL stock, worth $137,391. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,221Holding current value
$137,391% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding AVXL
# of Institutions
182Shares Held
28.9MCall Options Held
749KPut Options Held
825K-
Black Rock Inc. New York, NY6.39MShares$54.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$39.6 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$20.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$15.9 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.13MShares$9.61 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $660M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...